Skip to main content

Table 1 Baseline recipient, donor and transplant procedure characteristics

From: Association of pre-transplant statin use with delayed graft function in kidney transplant recipients

Characteristics Statin Non-statin Total p-value
  N = 93 N = 176 N = 269  
Recipient characteristics     
Age (years) 53.7 ± 11.0 47.5 ± 13.5 49.7 ± 13.0 <0.001
Male gender (%) 62(67%) 115(65%) 177(66%) 0.83
Race     0.06
 Caucasian 81(87%) 150(85%) 231(86%)  
 Other 12(13%) 26(15%) 38(14%)  
Body Mass Index1 (kg/m2)     0.08
 <18,5 1(1%) 5(3%) 6(2%)  
 18.5-24.9 33(37%) 76(43%) 109(41%)  
 25-29.9 32(35%) 70(40%) 102(38%)  
 >30 24(27%) 25(14%) 49(19%)  
Co-morbidities     
 Hypertension 89(96%) 148(84%) 237(88%) 0.005
 Coronary artery disease 11(12%) 12(7%) 23(9%) 0.16
 Peripheral vascular disease 4(4%) 5(3%) 9(3%) 0.53
 Cerebrovascular disease 2(2%) 2(1%) 4(1%) 0.51
 Chronic lung disease 6(7%) 12(7%) 18(7%) 0.91
 Diabetes mellitus 9(10%) 12(7%) 21(8%) 0.41
Smoker     0.78
 Current 1(1%) 1(1%) 2(1%)  
 Former 41(44%) 84(48%) 125(46%)  
 Never 51(55%) 91(51%) 142(53%)  
Etiology of ESRD     0.18
 Polycystic kidney disease 23(25%) 30(17%) 53(19%)  
 Glomerulonephritis 14(15%) 33(19%) 47(17%)  
 Focal sclerosing 4(4%) 6(3%) 10(4%)  
 Focal and segmental proliferative 0(0%) 9(5%) 9(3%)  
 IgA nephropathy 14(15%) 29(16%) 43(16%)  
 Reflux nephropathy 8(9%) 19(11%) 27(10%)  
 Diabetic nephropathy 7 (8%) 4 (2%) 11 (4%)  
 Other 27(29%) 61(35%) 88(33%)  
Renal replacement therapy     0.55
 Haemodialysis 56(60%) 97(55%) 153(57%)  
 Peritoneal dialysis 27(29%) 52(30%) 79(29%)  
 None 10(11%) 27(15%) 37(14%)  
Previous transplants 15% 9% 11% 0.10
Length of admission (days) 8.6 ± 4.2 7.9 ± 3.8 8.2 ± 4.0 0.19
Donor characteristics     
Age at transplant (years) 47.8 ± 14.6 44.0 ± 15.2 45.33 ± 13.02 0.05
Male gender (%) 42(45%) 83(47%) 125(47%) 0.76
Body Mass Index1 (kg/m2)     0.23
 <18.5 0(0%) 8(5%) 8(3%)  
 18.5-24.9 32(35%) 57(33%) 89(34%)  
 25-29.9 42(46%) 76(43%) 108(45%)  
 >30 17(19%) 32(19%) 49(18%)  
Co-morbidities     
 Hypertension 14(15%) 20(11%) 34(13%) 0.38
 Hypertension 14(15%) 20(11%) 34(13%) 0.38
 Diabetes 2(2%) 4(2%) 6(2%) 0.83
 Current 23(25%) 49(28%) 72(27%)  
 Former 21(22%) 36(20%) 56(21%)  
 Never 49(53%) 91(52%) 140(52%)  
Donor type     0.35
 Donation after brain death 49(53%) 94(53%) 143(53%)  
 Donation after cardiac death 13(14%) 15(9%) 28(10%)  
 Life 31(33%) 67(38%) 98(37%)  
Cause of death 0.36    
 Subarachnoid haemorrhage 22(36%) 28(26%) 50(29%)  
 Cardiac arrest 6(10%) 19(17%) 25(15%)  
 Intracranial haemorrhage 9(14%) 15(14%) 24(14%)  
 Cyclist 6(10%) 4(4%) 10(6%)  
 Fall 4(6%) 5(4%) 9(5%)  
 Traffic accident 2(3%) 5(4%) 7(4%)  
 Hypoxia 3(5%) 4(4%) 7(4%)  
 Other 10(16%) 29(27%) 39(23%)  
Inotropic support 52(84%) 95(87%) 147(86%) 0.55
eGFR (mL/min/1.73 m2) 90.8 ± 22.8 94.4 ± 25.0 93.2 ± 24.3 0.25
Transplant procedure characteristics     
Mismatch 3(2–5) 4(2–5) 4(2–5) 0.05
Cold ischaemic time (hours) 8.2 ± 4.5 7.6 ± 4.5 7.7 ± 4.5 0.29
Warm ischaemic time (hours) 0.6 ± 0.2 0.6 ± 0.2 0.6 ± 0.2 0.93
  1. 1BMI classification according to the WHO.